Migraines and headaches, often triggered by stress and associated with irregular brain wave patterns, can also be alleviated. Neurofeedback helps individuals by promoting more balanced brain wave activity, which can potentially reduce the frequency and intensity of migraine attacks. Because neurofeedback encourages a more regulated brain response to stress and stimuli, it can become an effective preventative measure. This can result in lasting relief, a better quality of life and, for many, a reduction in the use of medications with side effects. Neurofeedback offers hope to headache and migraine sufferers, allowing them to regain control of their pain and improve their overall well-being.

Othmer was one of the first to successfully use neurofeedback for migraines. For left-sided headaches, patients were taught to decrease 2-7 Hz and high beta activity and increase 15-18 Hz, while similarly for right-sided headaches, low and high frequency activity was trained down and 12-15 Hz up (Othmer, 1994).

A slightly modified version of the aforementioned training, where the theta (4-7Hz) activity was trained down and the SMR (12-15Hz) activity was trained up, proved to be effective in alleviating headaches (Tansy, 1991). Phase training of the T3-T4 points of the two cerebral hemispheres was also found to be effective in the case of migraine, which also had a good effect on mood (Othmer and Othmer, 2001). In children with migraine (without aura), the training of the control of slow cortical activity was successfully used to eliminate pain, which was enough for 10 sessions (Siniatchkin et al., 2000).

In another 2011 study, 71 people diagnosed with migraine (without aura) took part, of whom 46 received neurofeedback training and 25 chose traditional drug treatment (Walker, 2011). In neurofeedback, the reduction of the 21-30Hz activity and the increase of the 10Hz activity were taught, 5 times per hemisphere for the brain hemispheres affected by pain. In the neurofeedback training group, the majority (54%) reported a complete cessation of pain, many (39%) reported a reduction in the frequency of pain by more than 50%, and some (4%) reported a reduction in the occurrence of pain by less than 50%. about the decrease. In the medication group, the majority (68%) did not reduce the frequency of pain, in a few (20%) the frequency of pain decreased by less than 50%.